Daniel Steiner, Ph.D.SVP, Oncology Research at Molecular Partners
Profile
Daniel Steiner is SVP Research of Molecular Partners. In his previous role with Molecular Partners, Daniel built the department responsible for DARPin generation for all research pipeline projects, specifically establishing the DARPin platform for systemic PK-extension. While earning his Ph.D. at the University of Zurich under Prof Andreas Plückthun, Daniel established a novel in vitro selection system enabling the efficient selection of DARPins for complex antigens. In addition to his doctorate studies at University of Zurich, Daniel performed his undergraduate studies at the ETH Zürich and at the Imperial College London.
Agenda Sessions
KEYNOTE: Ensovibep, a clinical stage DARPin Therapeutic for SARS-CoV-2
9:00amView Session